Cerebral microbleeds and acute myocardial infarction: Screening and disease progression.

Fiche publication


Date publication

juin 2020

Journal

International journal of cardiology. Heart & vasculature

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves


Tous les auteurs :
Alaa El Din A, Debeaumarche H, Thouant P, Maza M, Ricolfi F, Zeller M, Bichat F, Baudouin N, Bejot Y, Cottin Y

Résumé

Cerebral microbleeds (CMB) are associated with intracerebral haemorrhage. Therefore they may represent a concern if anticoagulant and/or antiplatelet therapy is needed. The aim of this study was to determine the prevalence of CMB in patients with acute myocardial infarction (AMI), and to follow their progression at 3 months under dual antiplatelet therapy (DAPT).

Mots clés

3 months, Acute myocardial infarction, Anticoagulant treatment, Cerebral MRI, Cerebral microbleeds

Référence

Int J Cardiol Heart Vasc. 2020 Jun;28:100531